Table 1.
Outcomes used.
| Outcome description | Correlates with CDA guideline number (1) | |
|---|---|---|
| Primary outcome | (1) Percentage of patients in which glycosylated haemoglobin (A1c) targets were reached (≤7.00) | 1 |
|
| ||
| Secondary outcomes | (1) Percentage of patients who reached the following glycemic targets; at least 4 A1c readings in a 1-year period and a mean fasting plasma glucose (FPG) within target of 4.0–7.0 mmol/L | 1 |
| (2) Percentage of patients who were managed by lifestyle modification as documented in their chart and other descriptive information about glycemic management | 5 | |
| (3) Percentage of patients exercising regularly as documented in their chart and other descriptive information about diet and exercise | 4 | |
| (4) Prevalence of comorbidities (hypertension, dyslipidemia, retinopathy/neuropathy/nephropathy, cerebrovascular disease, coronary artery disease, and specialist consultations | ||
| (5) Percentage of patients reaching blood pressure targets | 3 | |
| (6) Percentage of patients who had lipids monitored | 2 | |
| (7) Percentage of patients who were prescribed aspirin and ACE inhibitor medication | 8 and 9 | |
| (8) Percentage of patients in whom there was documentation of smoking and alcohol consumption status | 6 and 7 | |
| (9) Percentage of patients in whom there was documentation of body mass index | ||